10:06 EST Mirum Pharmaceuticals (MIRM) sees FY26 global net product sales $630M-$650M
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIRM:
- Mirum Pharmaceuticals falls -16.5%
- Mirum Pharmaceuticals price target raised to $130 from $123 at Morgan Stanley
- Mirum Pharmaceuticals price target raised to $117 from $115 at TD Cowen
- Mirum Pharmaceuticals price target lowered to $128 from $130 at RBC Capital
- Mirum Pharmaceuticals price target raised to $125 from $98 at Stifel